- Home
- AVIR vs ACV Comparison
AVIR vs ACV Comparison
Compare AVIR & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ACV
- Stock Information
- Founded
- AVIR 2012
- ACV 2015
- Country
- AVIR United States
- ACV United States
- Employees
- AVIR N/A
- ACV N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ACV Finance/Investors Services
- Sector
- AVIR Health Care
- ACV Finance
- Exchange
- AVIR Nasdaq
- ACV Nasdaq
- Market Cap
- AVIR 290.4M
- ACV 234.1M
- IPO Year
- AVIR 2020
- ACV N/A
- Fundamental
- Price
- AVIR $3.37
- ACV $23.47
- Analyst Decision
- AVIR Hold
- ACV
- Analyst Count
- AVIR 1
- ACV 0
- Target Price
- AVIR $6.00
- ACV N/A
- AVG Volume (30 Days)
- AVIR 306.9K
- ACV 38.8K
- Earning Date
- AVIR 11-06-2025
- ACV 01-01-0001
- Dividend Yield
- AVIR N/A
- ACV 9.20%
- EPS Growth
- AVIR N/A
- ACV N/A
- EPS
- AVIR N/A
- ACV N/A
- Revenue
- AVIR N/A
- ACV N/A
- Revenue This Year
- AVIR N/A
- ACV N/A
- Revenue Next Year
- AVIR N/A
- ACV N/A
- P/E Ratio
- AVIR N/A
- ACV N/A
- Revenue Growth
- AVIR N/A
- ACV N/A
- 52 Week Low
- AVIR $2.46
- ACV $16.82
- 52 Week High
- AVIR $4.15
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- AVIR 42.27
- ACV 69.25
- Support Level
- AVIR $3.35
- ACV $22.95
- Resistance Level
- AVIR $3.86
- ACV $23.20
- Average True Range (ATR)
- AVIR 0.13
- ACV 0.26
- MACD
- AVIR -0.02
- ACV 0.07
- Stochastic Oscillator
- AVIR 14.78
- ACV 100.00
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.